A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein

Journal of Cell Biology

Volumn 172, Issue 4, 2006, Pages 497-504

  Qin, Qingyu ^a,b   Inatome, Ryoko ^a,b   Hotta, Azusa ^a,b   Kojima, Masaki ^a   Yamamura, Hirohei ^b   Hirai, Hirokazu ^c,d   Yoshizawa, Toshihiro ^e   Tanaka, Hirofumi ^a   Fukami, Kiyoko ^a   Yanagi, Shigeru ^a,d  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRAG PROTEIN; GUANOSINE TRIPHOSPHATASE; POLYGLUTAMINE; PROMYELOCYTIC LEUKEMIA PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; STRESS; ULTRAVIOLET IRRADIATION;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; GTP PHOSPHOHYDROLASES; HELA CELLS; HUMANS; INTRANUCLEAR INCLUSION BODIES; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NUCLEAR LOCALIZATION SIGNALS; NUCLEAR PROTEINS; PEPTIDES; RATS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-ACTIVATING ENZYMES; UBIQUITIN-CONJUGATING ENZYMES; ULTRAVIOLET RAYS;

EID: 32644433693     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200505079     Document Type: Article

References (17)

1. Der, C.J., T. Finkel, and G.M. Cooper. 1986. Biological and biochemical properties of human rasH genes mutated at codon 61. Cell. 44:167-176.
2. Hodges, M., C. Tissot, K. Howe, D. Grimwade, and P.S. Freemont. 1998. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am. J. Hum. Genet. 63:297-304.
3. Honda, R., H. Tanaka, and H. Yasuda. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:25-27.
4. Hotta, A., R. Inatome, J. Yuasa-Kawada, Q. Qin, H. Yamamura, and S. Yanagi. 2005. Critical role of CRMP-associated molecule CRAM for filopodia and growth cone development in neurons. Mol. Biol. Cell. 16:32-39.
5. Inatome, R., T. Tsujimura, T. Hitomi, N. Mitsui, P. Hermann, S. Kuroda, H. Yamamura, and S. Yanagi. 2000. Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain. J. Biol. Chem. 275:27291-27302.
6. Katsuno, M., H. Adachi, A. Inukai, and G. Sobue. 2003. Transgenic mouse models of spinal and bulbar muscular atrophy (SBMA). Cytogenet. Genome Res. 100:243-251.
7. Kobirumaki, F., Y. Miyauchi, K. Fukami, and H. Tanaka. 2005. A novel UbcH10-binding protein facilitates the ubiquitinylation of cyclin B in vitro. J. Biochem. (Tokyo). 137:133-139.
8. Lamond, A.I., and W.C. Earnshaw. 1998. Structure and function in the nucleus. Science. 280:547-553.
9. Mitsui, N., R. Inatome, S. Takahashi, Y. Goshima, H. Yamamura, and S. Yanagi. 2002. Involvement of Fes/Fps tyrosine kinase in semaphorin3A signaling. EMBO J. 21:3274-3285.
10. Orr, H.T. 2001. Beyond the Qs in the polyglutamine diseases. Genes Dev. 15:925-932.
11. Ross, C.A. 1997. Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron. 19:1147-1150.
12. Sato, A., T. Shimohata, R. Koide, H. Takano, T. Sato, M. Oyake, S. Igarashi, K. Tanaka, T. Inuzuka, H. Nawa, and S. Tsuji. 1999. Adenovirus-mediated expression of mutant DRPLA proteins with expanded polyglutamine stretches in neuronally differentiated PC12 cells. Preferential intranuclear aggregate formation and apoptosis. Hum. Mol. Genet. 8:997-1006.
13. Takahashi, J., H. Fujigasaki, K. Iwabuchi, A.C. Bruni, T. Uchihara, K.H. El Hachimi, G. Stevanin, A. Durr, A.S. Lebre, Y. Trottier, et al. 2003. PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases. Neurobiol. Dis. 13:230-237.
14. Turmaine, M., A. Raza, A. Mahal, L. Mangiarini, G.P. Bates, and S.W. Davies. 2000. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntingtons disease. Proc. Natl. Acad. Sci. USA. 97:8093-8097.
15. Ye, K., K.J. Hurt, F.Y. Wu, M. Fang, H.R. Luo, J.J. Hong, S. Blackshaw, C.D. Ferris, and S.H. Snyder. 2000. Pike. A nuclear GTPase that enhances PI3kinase activity and is regulated by protein 4.1N. Cell. 103:919-930.
16. Yoshizawa, T., O. Shinmi, A. Giaid, M. Yanagisawa, S.J. Gibson, S. Kimura, Y. Uchiyama, J.M. Polak, T. Masaki, and I. Kanazawa. 1990. Endothelin: a novel peptide in the posterior pituitary system. Science. 247:462-464.
17. Yoshizawa, T., Y. Yamagishi, N. Koseki, J. Goto, H. Yoshida, F. Shibasaki, S. Shoji, and I. Kanazawa. 2000. Cell cycle arrest enhances the in vitro cellular toxicity of the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch. Hum. Mol. Genet. 9:69-78.